Hermann Ammer

854 total citations
41 papers, 729 citations indexed

About

Hermann Ammer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Hermann Ammer has authored 41 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in Hermann Ammer's work include Receptor Mechanisms and Signaling (24 papers), Neuropeptides and Animal Physiology (21 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Hermann Ammer is often cited by papers focused on Receptor Mechanisms and Signaling (24 papers), Neuropeptides and Animal Physiology (21 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Hermann Ammer collaborates with scholars based in Germany, Czechia and United States. Hermann Ammer's co-authors include Rüdiger Schulz, Jürgen Kraus, Helmut Schröder, Christine Börner, Volker Höllt, Angelika M. Vollmar, Carola Sauter‐Louis, Robert Fürst, Stefan Zahler and Katrin Hartmann and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Hermann Ammer

39 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann Ammer Germany 18 468 444 137 69 43 41 729
Géza Szűcs Hungary 16 523 1.1× 329 0.7× 50 0.4× 30 0.4× 31 0.7× 34 807
B Hunyady Hungary 10 373 0.8× 175 0.4× 130 0.9× 44 0.6× 34 0.8× 33 873
Abhishek Chandra United States 13 406 0.9× 208 0.5× 162 1.2× 29 0.4× 19 0.4× 15 685
Stephen Hadley United States 12 298 0.6× 323 0.7× 82 0.6× 37 0.5× 49 1.1× 19 1.0k
Yunjia Chen United States 16 592 1.3× 265 0.6× 229 1.7× 52 0.8× 90 2.1× 39 1.1k
Mariusz Sacharczuk Poland 16 228 0.5× 189 0.4× 126 0.9× 50 0.7× 45 1.0× 89 799
Krzysztof Wąsowicz Poland 14 213 0.5× 454 1.0× 124 0.9× 24 0.3× 19 0.4× 83 792
R. Laufer Italy 16 928 2.0× 863 1.9× 190 1.4× 58 0.8× 39 0.9× 26 1.3k
F. Esclaire France 15 237 0.5× 247 0.6× 178 1.3× 26 0.4× 52 1.2× 19 575
Katharina Held Belgium 13 264 0.6× 259 0.6× 222 1.6× 38 0.6× 19 0.4× 23 862

Countries citing papers authored by Hermann Ammer

Since Specialization
Citations

This map shows the geographic impact of Hermann Ammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Ammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Ammer more than expected).

Fields of papers citing papers by Hermann Ammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Ammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Ammer. The network helps show where Hermann Ammer may publish in the future.

Co-authorship network of co-authors of Hermann Ammer

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann Ammer. A scholar is included among the top collaborators of Hermann Ammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann Ammer. Hermann Ammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Suchismita, Britta Nubbemeyer, Curran A. Rhodes, et al.. (2023). Bicyclic Peptide Library Screening for the Identification of Gαi Protein Modulators. Journal of Medicinal Chemistry. 66(17). 12396–12406. 2 indexed citations
2.
Muhar, Matthias, et al.. (2013). Difficulties in Generating Specific Antibodies for Immunohistochemical Detection of Nitrosylated Tubulins. PLoS ONE. 8(6). e68168–e68168. 7 indexed citations
3.
Zuo, Hao, Anthony S.L. Chan, Hermann Ammer, & Yung Hou Wong. (2013). Activation of Gαq subunits up-regulates the expression of the tumor suppressor Fhit. Cellular Signalling. 25(12). 2440–2452. 3 indexed citations
4.
Bihari, Péter, Guido Jürgenliemk, Hermann Ammer, et al.. (2011). A novel approach to prevent endothelial hyperpermeability: The Crataegus extract WS® 1442 targets the cAMP/Rap1 pathway. Journal of Molecular and Cellular Cardiology. 52(1). 196–205. 29 indexed citations
6.
Ammer, Hermann, et al.. (2009). Down-regulation of c-Cbl by Morphine Accounts for Persistent ERK1/2 Signaling in δ-Opioid Receptor-expressing HEK293 Cells. Journal of Biological Chemistry. 284(50). 34819–34828. 11 indexed citations
7.
Ammer, Hermann, et al.. (2009). δ-Opioid receptor-stimulated Akt signaling in neuroblastoma × glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation. Experimental Cell Research. 315(12). 2115–2125. 31 indexed citations
8.
Liebl, Johanna, et al.. (2008). Ginkgo biloba extract EGb® 761 exerts anti‐angiogenic effects via activation of tyrosine phosphatases. Journal of Cellular and Molecular Medicine. 13(8b). 2122–2130. 19 indexed citations
9.
Ammer, Hermann, et al.. (2008). δ-Opioid receptors activate ERK/MAP kinase via integrin-stimulated receptor tyrosine kinases. Cellular Signalling. 20(12). 2324–2331. 35 indexed citations
10.
Ammer, Hermann, et al.. (2008). δ‐Opioid receptors stimulate ERK1/2 activity in NG108‐15 hybrid cells by integrin‐mediated transactivation of TrkA receptors. FEBS Letters. 582(23-24). 3325–3329. 11 indexed citations
11.
Abraham, Getu, et al.. (2006). Segment-dependent Expression of Muscarinic Acetylcholine Receptors and G-protein Coupling in the Equine Respiratory Tract. Veterinary Research Communications. 31(2). 207–226. 10 indexed citations
12.
Börner, Christine, Jürgen Kraus, Helmut Schröder, Hermann Ammer, & Volker Höllt. (2004). Transcriptional Regulation of the Human μ-Opioid Receptor Gene by Interleukin-6. Molecular Pharmacology. 66(6). 1719–1726. 57 indexed citations
13.
Ammer, Hermann & Rüdiger Schulz. (1998). Adenylyl Cyclase Supersensitivity in Opioid-Withdrawn NG108–15 Hybrid Cells Requires Gs but Is Not Mediated by the Gsα Subunit. Journal of Pharmacology and Experimental Therapeutics. 286(2). 855–862. 15 indexed citations
14.
Ammer, Hermann & Rüdiger Schulz. (1997). Enhanced Stimulatory Adenylyl Cyclase Signaling during Opioid Dependence Is Associated with a Reduction in Palmitoylated Gsα. Molecular Pharmacology. 52(6). 993–999. 45 indexed citations
15.
Ammer, Hermann & Rüdiger Schulz. (1996). Chronic exposure of NG108-15 cells to inhibitory acting drugs reduces stimulatory prostaglandin E1 receptor number. European Journal of Pharmacology. 302(1-3). 199–205. 7 indexed citations
16.
Ammer, Hermann & Rüdiger Schulz. (1996). Stable Expression and Functional Characterization of the Cloned Rat μ‐opioid Receptor in Human Epidermoid Carcinoma (A431) Cells*. Journal of Veterinary Medicine Series A. 43(1-10). 193–200. 3 indexed citations
18.
Ammer, Hermann & Rüdiger Schulz. (1994). Retinoic Acid‐Induced Differentiation of Human Neuroblastoma SH‐SY5Y Cells Is Associated with Changes in the Abundance of G Proteins. Journal of Neurochemistry. 62(4). 1310–1318. 44 indexed citations
20.
Ammer, Hermann, et al.. (1991). Regulation of G proteins by chronic opiate and clonidine treatment in the guinea pig myenteric plexus.. Journal of Pharmacology and Experimental Therapeutics. 258(3). 790–796. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026